Akab International Investment and Alifax join hands to bring Alifax Gulf to the region

AKAB, AliFax to launch Alifax Gulf in the UAE with expansion plans to cover all the GCC countries.

Akab International Investment and Alifax join hands to bring Alifax Gulf to the region
Alifax Gulf Brings Latest Microbiology Patent Instruments to UAE

Plans to expand business to cover all GCC countries
Dubai, UAE: AKAB International Investment (AKAB), the pioneer in transportation & logistics, construction and trading investment together with AliFax, one of the leading Italian companies specialized in the development, production and distribution of clinical diagnostic instrumentation, announced their joint venture and distribution agreements to launch Alifax Gulf in the UAE with expansion plans to cover all the GCC countries.

Alifax Gulf will bring the latest microbiology patent instruments to the UAE market to include ALIBOX, MOLECULAR MOUSE, HB&L-Alfred- Sidecar, HOTBLOOD and 1 Minute identification by ATR-FTIR. The products introduced will serve the healthcare industry, clinical diagnostic centers, laboratories and medical & science universities.

Mr. Ali Khalifa Bin Beyat, President of AKAB International Investment said: “Our unwavering commitment to quality products, international expansion and global partnerships & investments has given us a prominent position in the competitive trading community. We always strive to create value for all our stakeholders and for the communities we operate in, and we are proud to be launching Alifax Gulf in the UAE and GCC markets to introduce the latest state-of-the-art microbiology instruments that caters to a wide range of industry stakeholders.”

“Alifax is strongly oriented towards scientific research and technological innovation supported by constant investment program. We understand the market needs and promptly answers the worldwide demand. Our partnership with AKAB will help us extend our distribution reach and bring our latest clinical diagnostic instrumentation to the Middle East and fulfilling the market demands.” said Dr. Paolo Galiano, President of Alifax.

Alifax diagnostic systems and kits are developed with the main focus on the total laboratory automation requirements providing fast and reliable results, method standardization, sample traceability and easy to use protocols. Alifax efforts are focused on tailoring innovative solutions to answer the market needs and improving the clinical diagnostics workflow and the patient management.



The new technological solution to improve the transport of biological samples with active temperature control and cloud monitoring service. ALIBOX is constantly connected with a cloud-based monitoring platform and operated under a precisely defined and documented process. All monitored data transmitted to the cloud can be reviewed by user through PC, tablet or smart phone.


The world’s first handheld qPCR system with Lab-on-Chip. Provides Qualitative, Quantitative and Fast analysis of DNA and RNA target molecules through real-time PCR. It is Compact, Easy to use and time to results: 30 min.  Molecular Mouse can be managed using the user’s smartphone

HB&L-Alfred- Sidecar:

Are based on laser scattering technology that detects the increase of turbidity due to the replication of bacteria. The software recognizes only the alive bacteria exponential growth and gives a quantitative result in CFU/mL. Is the fastest real cultural method and gives final results in 3 hours for the urine culture instead overnight incubation that is needed for the traditional culture method. The applications available are for urine culture, body fluids, MDRO screening, antimicrobial sensitivity test in 3-5 hours, and microbiological suitability of the cornea transport and storage media. Soon a new test for Mycobacterium tuberculosis culture and resistance detection will be available on a new version of HB&L system.


-  HbA1c and ESR test from the same EDTA blood tube.

-  Quantitative measurement of HbA1c by Boronate Fluroscence quenching technology.

- HbA1c result in 3 minutes.

-  ESR result in 20 seconds.

1 Minute identification by ATR-FTIR

-  Next generation microorganism ID by ATR-FTIR technology.

- Time to result: 1 minute from isolated colony or bacteria pellet from our broth.

About AKAB

AKAB International Investment was founded in the year 2000 by visionary Emirati entrepreneur Ali Khalifa Bin Beyat. The Group employees over 2,000 people working across UAE, Saudi Arabia and Europe.

The Group’s objective is to enhance its global presence through partnerships, acquisitions, international investments, joint ventures and representatives of world-renowned brands in global markets.

AKAB International Investment had been present in a number of areas, projects and organizations in various verticals such as logistics, transportation consultancy, warehousing, trading, construction and real estate, medical technology, automotive, amongst others.

Companies that operate under the Group include Allied Transport, No1 Transport, AB Express, Emirates Express, Eastern Allied Transport, Allied Construction, Basic Medical and Alifax Gulf.

About Alifax

Alifax was founded in 1988 in Padova by Paolo Galiano as a result of his valuable experience in the laboratory diagnostic market with special reference to hematology, microbiology, serology and autoimmunity fields.

In 1998 after the acquisition of Sire Analytical Systems, Alifax asserted its position in the Italian market as producer of clinical diagnostic instrumentation for the analysis of Erythrocyte Sedimentation Rate and rapid bacterial culture. This is the inception of a rapid and successful development worldwide. Nowadays Alifax is present with 3 subsidiaries in Russia, Spain and China and a distribution network that includes more than 90 countries around the world.

Alifax understands the market needs and promptly answers the worldwide demand through its technical scientific infrastructure represented by highly qualified staff in the field of laboratory medicine, engineering and information technology. Alifax is strongly oriented towards scientific research and technological innovation supported by constant investment program.

For more information please contact:
Fekra Communications
Mohammed El Batta
T: +971 4 4317178 | M: +971 55 5542678
E: mohammed.elbatta@fekracomms.com | www.fekracomms.com

© Press Release 2017

More From Press Releases